Percutaneous Arterial Closure Devices

Hoffer, Eric K.; Bloch, Robert D.

doi:10.1097/01.rvi.0000071086.76348.8e

Cited by 97 publications

(64 citation statements)

References 60 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The efficacy and safety of various closure devices have been evaluated in patients undergoing coronary intervention [5,9] and in patients with PAOD, with efficacy ranging from approximately 80-96% [8,15,16]. In our device population, immediate hemostasis could be achieved in 95% of cases, which is similar to reported findings with other closure devices [5,12,16].…”

Section: Discussionsupporting

confidence: 84%

“…Both collagen-based and suture-based closure systems have been evaluated in studies with large patient populations [5,8]. While some studies report a decreased time to ambulation [4,8,9], others [10] could not show the superiority of closure compared with manual compression.…”

Section: Discussionmentioning

confidence: 99%

“…In addition, with collagen-based devices, repeated access at the same site is impaired until complete resorption of the intravascular anchor of the collagen plug has been achieved. So far, none of these devices is a completely satisfactory solution to maximizing patient safety and comfort or to shortening hospital stay [5].…”

Section: Discussionmentioning

confidence: 99%

“…Several systems, widely ranged in price, are available. All require training prior to application [3][4][5].…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Postinterventional percutaneous closure of femoral artery access sites using the Clo-Sur PAD device: initial findings

et al. 2006

View full text Add to dashboard Cite

The purpose of this study was to evaluate a percutaneous hemostatic device in patients to achieve immediate hemostasis at the vascular access site as well as early ambulation after vascular interventional procedures. In a randomized trial, a hemostatic device (Clo-Sur PAD, Medtronic AVE, Inc., Santa Rosa, CA, USA; n=60) was compared with manual compression (n=60) in patients after endoluminal intervention through an inguinal access (sheath sizes: 5-7 French). Device safety was evaluated by assessing complications within 24 h and 14 days. System efficacy was measured by the percentage of achieved immediate hemostasis and early ambulation. Device application was possible in 57 cases (95.0%), with 93.3% (56/60) of the patients rising 2 h after application. Hemostasis time was 10.15+/-1.96 min (control group: 16.20+/-1.79 min), with a pressure bandage time of 3.47+/-5.53 h (control group: 13.8+/-4.32 h). Ambulation was possible after 2.13+/-0.50 h (control group: 8.57+/-3.47 h). Complications encountered were access-site bleeding with hematoma (device: n=3; control: n=9). All complications were managed conventionally without blood transfusion or surgical intervention. The system is an easy to use device permitting early ambulation without additional pressure bandaging in the majority of patients. Preliminary data show that hemostasis does not depend on the level of anticoagulation.

show abstract

Section: Discussionsupporting

confidence: 84%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

“…Several systems, widely ranged in price, are available. All require training prior to application [3][4][5].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Postinterventional percutaneous closure of femoral artery access sites using the Clo-Sur PAD device: initial findings

et al. 2006

View full text Add to dashboard Cite

show abstract

“…Most of the patients had many of the factors summarized in Table 2, regardless of their group affiliation. Our hypothesis is supported by many studies that showed the influence of coexisting factors included in Table 2 on the rate of VCD-related access site complications [21]. Moreover, descriptive box plot analysis revealed trends toward the anticipated direction.…”

Section: Discussionsupporting

confidence: 69%

The Use of the “Preclosure” Technique for Antegrade Aspiration Thrombectomy with Large Catheters in Acute Limb Ischemia

Funke

Pfiffner

Husmann

et al. 2012

Cardiovasc Intervent Radiol

View full text Add to dashboard Cite

PURPOSE: This study was designed to assess retrospectively short-and mid-term outcomes of the use of a suture-mediated closure device to close the antegrade access in patients undergoing percutaneous aspiration thrombectomy with large catheters for acute leg ischemia. METHODS: Between November 2005 and February 2010, a suture-mediated active closure system (ProGlide(®) 6F, Abbott) was placed before arterial sheath (mean 9 F, range 6-12 F) introduction in 101 patients (74 men, 73 %, mean age 70.1 ± 12.6 years standard deviation). Data regarding mortality, complications, and factors contributing to vascular complications at the access site was collected for 6 month after the intervention to detect device-related problems. As a coincidence, 77 patients had follow-up visits for a duplex ultrasound. RESULTS: There were a total of 19 vascular complications (19 %) at the puncture site, all of which were of hemorrhagic nature and none of which consisted of vessel occlusion. Two major outcome complications (2 %) occurred. A retroperitoneal hematoma and a serious inguinal bleeding required additive treatment and did not result in permanent sequelae. Nine cases involved death of which eight were not attributable to the closure and one remained unclear. Successful closure was achieved in 95 patients (94 %); additional manual compression was sufficient in the majority of the remaining patients. Numerous factors contributing to vascular complications were encountered. CONCLUSIONS: With acceptable short-and mid-term outcomes, the "preclose" technique can be a reliable option for the closure of a large antegrade femoral access even for patients at a high risk of vascular complications, such as those undergoing aspiration thrombectomy. Abstract Purpose This study was designed to assess retrospectively short-and mid-term outcomes of the use of a suturemediated closure device to close the antegrade access in patients undergoing percutaneous aspiration thrombectomy with large catheters for acute leg ischemia. Methods Between November 2005 and February 2010, a suture-mediated active closure system (ProGlide Ò 6F, Abbott) was placed before arterial sheath (mean 9 F, range 6-12 F) introduction in 101 patients (74 men, 73 %, mean age 70.1 ± 12.6 years standard deviation). Data regarding mortality, complications, and factors contributing to vascular complications at the access site was collected for 6 month after the intervention to detect device-related problems. As a coincidence, 77 patients had follow-up visits for a duplex ultrasound. Results There were a total of 19 vascular complications (19 %) at the puncture site, all of which were of hemorrhagic nature and none of which consisted of vessel occlusion. Two major outcome complications (2 %) occurred. A retroperitoneal hematoma and a serious inguinal bleeding required additive treatment and did not result in permanent sequelae. Nine cases involved death of which eight were not attributable to the closure and one remained unclear. Successful closure was achieved in 95 pati...

show abstract

Interventional Oncology

BVSc¹,

Séguin²

2012

Veterinary Surgical Oncology

View full text Add to dashboard Cite

Percutaneous Arterial Closure Devices

Cited by 97 publications

References 60 publications

Postinterventional percutaneous closure of femoral artery access sites using the Clo-Sur PAD device: initial findings

Postinterventional percutaneous closure of femoral artery access sites using the Clo-Sur PAD device: initial findings

The Use of the “Preclosure” Technique for Antegrade Aspiration Thrombectomy with Large Catheters in Acute Limb Ischemia

Interventional Oncology

Contact Info

Product

Resources

About